Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) leads to multiple metabolic changes, reduction in glucose levels and body weight are well established. In people with type 2 diabetes, GLP-1...

Source: Cardiovascular Diabetology - December 17, 2021 Category: Cardiology Authors: J. Jendle, T. Hy ötyläinen, M. Orešič and T. Nyström Tags: Original investigation Source Type: research